Clinical genomic testing has been made possible by the development of "next-generation" sequencing (NGS) technologies that allow large quantities of nucleic acid sequence to be obtained in a clinically meaningful time frame. This chapter reviews the sequencing platforms that are currently in most common use, including Illumina, Ion Torrent, SOLiD, and Roche 454. Sanger sequencing is discussed as a "first-generation" technology that retains an important place in clinical genomics for orthogonal validation of NGS findings and for coverage of areas not amenable to NGS.
|Title of host publication||Clinical Genomics|
|Number of pages||17|
|State||Published - Jan 1 2015|
- Massively parallel sequencing
- Medical laboratory technologies